Back to Search
Start Over
Supplementary Figure S1 from FDA Approval Summary: Ivosidenib for Relapsed or Refractory Acute Myeloid Leukemia with an Isocitrate Dehydrogenase-1 Mutation
- Publication Year :
- 2023
- Publisher :
- American Association for Cancer Research (AACR), 2023.
-
Abstract
- Rate of CR+CRh by subgroup
Details
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....2be902c39ee395a68d595086357bb634
- Full Text :
- https://doi.org/10.1158/1078-0432.22469381.v1